ibuprofen has been researched along with zithromax in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (41.18) | 29.6817 |
| 2010's | 8 (47.06) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Coleman, EJ; Mandell, GL | 1 |
| Beltrán Bengoechea, B; Girón Moreno, R; Salcedo Posadas, A | 1 |
| Dinwiddie, R | 1 |
| Chandra, JA; Garg, R; Vatsal, P; Zahra, F | 1 |
| Alechaga, E; Boleda, MR; Galceran, MT; Moyano, E; Ventura, F | 1 |
| Cao, H; Chen, W; Feng, B; Gao, C; Muhammad, W; Wang, R; Wang, S; Xie, J; Xu, Y; Yao, Q; Yu, Y; Zhang, Y; Zhou, J; Zhu, J | 1 |
3 review(s) available for ibuprofen and zithromax
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Complementary therapies in cystic fibrosis: evidence of therapeutic benefits and treatment recommendations].
Topics: Azithromycin; Bronchodilator Agents; Child; Complementary Therapies; Cystic Fibrosis; Deoxyribonucleases; Glucocorticoids; Humans; Ibuprofen; Practice Guidelines as Topic | 2003 |
Anti-inflammatory therapy in cystic fibrosis.
Topics: Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azithromycin; Cystic Fibrosis; Humans; Ibuprofen; Immunoglobulins; Macrolides | 2005 |
1 trial(s) available for ibuprofen and zithromax
| Article | Year |
|---|---|
A comparative study of injection placentrex and conventional therapy in treatment of pelvic inflammatory disease.
Topics: Abdominal Pain; Adnexal Diseases; Adult; Alkylating Agents; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Azithromycin; Doxycycline; Dysmenorrhea; Female; Humans; Ibuprofen; Metronidazole; Middle Aged; Pelvic Inflammatory Disease; Placental Extracts; Tinidazole; Young Adult | 2008 |
13 other study(ies) available for ibuprofen and zithromax
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Effect of antipyretic agents on uptake, transport, and release of antimicrobial agents by human polymorphonuclear leukocytes.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Anti-Bacterial Agents; Aspirin; Aza Compounds; Azithromycin; Biological Transport; Cell Movement; Fluoroquinolones; Humans; Ibuprofen; Microbial Sensitivity Tests; Moxifloxacin; Neutrophils; Quinolines | 2002 |
Survey of the occurrence of pharmaceuticals in Spanish finished drinking waters.
Topics: Azithromycin; Chromatography, Liquid; Clarithromycin; Drinking Water; Environmental Monitoring; Erythromycin; Ibuprofen; Pharmaceutical Preparations; Spain; Sulfamethoxazole; Tandem Mass Spectrometry; Water Pollutants, Chemical | 2014 |
Co-delivery of azithromycin and ibuprofen by ROS-responsive polymer nanoparticles synergistically attenuates the acute lung injury.
Topics: Acute Lung Injury; Azithromycin; Bacterial Infections; Humans; Ibuprofen; Inflammation; Nanoparticles; Polymers; Reactive Oxygen Species | 2023 |